Overview
- 97 inspections across 84 sites are on record.
- 318 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-26.
At a glance
Inspections
97
Sites
84
Observations
318
Career since
Mar 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Terumo BCT Ltd | 26 Jun 2026 | Biologics | View 483 → |
| Laboratorios Grifols, S.A. | 19 Jun 2026 | Biologics | |
| Bright Cell Inc | 15 May 2026 | Biologics | View 483 → |
| GVS TM, Inc | 1 May 2026 | Biologics | View 483 → |
| Dendreon Pharmaceuticals LLC | 25 Mar 2026 | Biologics | View 483 → |
Sites inspected
Terumo BCT LtdLarne, United Kingdom1 insp.
Laboratorios Grifols, S.A.Parets Del Valles, Spain1 insp.
Bright Cell IncIrvine, United States1 insp.
GVS TM, IncCovina, United States1 insp.
Dendreon Pharmaceuticals LLCSeal Beach, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Laurissa S Flowers7 shared
Matthew J Gretkierewicz5 shared
Kelly D Moore5 shared
Dylan R Jock3 shared
Creighton T Tuzon3 shared
William F Lagud3 shared
Deepa E Vadakkan2 shared
Maurine Fadlalla2 shared
Richard L Bartlett2 shared
Celeta S Coves2 shared
Full investigator report
Get the verbatim findings behind Emily B Camire's 318 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site